Salona Global Medical Device Corporation (TSE:EVMT) has released an update.
Evome Medical Technologies Inc. has partnered with ICP Securities Inc. to enhance the liquidity and market presence of its shares on the TSX Venture Exchange through automated market making services. ICP will utilize its ICP Premium™ algorithm and will not receive performance-based fees or stock options for its services. The contract with ICP is set for four months with possible month-to-month extensions, aiming to stabilize the supply and demand for Evome’s shares.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.
